4/24/2014 - 11:44 AM EST - Endo International plc : announced today that affiliates of the company have acquired worldwide rights to Sumavel® DosePro® (sumatriptan injection) for subcutaneous use, a needle-free delivery system for sumatriptan, from Zogenix, Inc. Endo International plc
shares T.ENL are trading down $1.11 at $67.06.
